SG Americas Securities LLC Purchases New Shares in Balchem Corporation (NASDAQ:BCPC)

SG Americas Securities LLC acquired a new stake in Balchem Corporation (NASDAQ:BCPC - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 6,918 shares of the basic materials company's stock, valued at approximately $1,148,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Quadrant Capital Group LLC raised its stake in shares of Balchem by 8.2% during the 4th quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock worth $161,000 after purchasing an additional 75 shares in the last quarter. Covestor Ltd increased its position in Balchem by 93.8% during the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after buying an additional 76 shares during the period. Arizona State Retirement System increased its position in Balchem by 0.8% during the 4th quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock worth $1,534,000 after buying an additional 77 shares during the period. Vident Advisory LLC increased its position in Balchem by 6.0% during the 4th quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock worth $232,000 after buying an additional 80 shares during the period. Finally, Mackenzie Financial Corp grew its holdings in shares of Balchem by 2.2% during the 4th quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company's stock worth $626,000 after purchasing an additional 84 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on BCPC. HC Wainwright set a $180.00 target price on Balchem and gave the stock a "buy" rating in a report on Monday, April 28th. Wall Street Zen downgraded shares of Balchem from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Finally, Sidoti upgraded shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th.

Balchem Price Performance

Shares of Balchem stock traded down $3.76 on Friday, reaching $156.01. The stock had a trading volume of 283,441 shares, compared to its average volume of 141,328. The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18. The business's 50 day moving average is $163.09 and its two-hundred day moving average is $164.06. The company has a market cap of $5.09 billion, a P/E ratio of 37.41, a price-to-earnings-growth ratio of 3.37 and a beta of 0.91. Balchem Corporation has a 1 year low of $145.70 and a 1 year high of $186.03.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.03). The company had revenue of $250.52 million during the quarter, compared to the consensus estimate of $245.70 million. Balchem had a return on equity of 12.01% and a net margin of 14.16%. The firm's revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the company posted $1.03 earnings per share. As a group, research analysts anticipate that Balchem Corporation will post 4.64 EPS for the current year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.